Domo and Regional One Health Named 2023 Nucleus ROI Award Winners
2023年9月19日 - 5:05AM
ビジネスワイヤ(英語)
Regional One Health sees 190% ROI with a
payback period of 1.2 years after deploying Domo
Domo (Nasdaq: DOMO) announced today that it and Regional One
Health, a national leader in healthcare, received a Nucleus
Research ROI Award for achieving a total ROI of 190% through the
adoption of Domo’s data experience platform. The platform enabled
significant improvements in patient care, advanced operational
efficiencies and revenue for Regional One Health.
As a premier healthcare organization, Regional One Health aims
to transform the way it delivers healthcare through informed,
data-driven decisions. In collaboration with Domo, the team at
Regional One worked with physicians and nurses to identify the data
they rely on most when making decisions about care, such as length
of stay and patient satisfaction, and leverage the Domo platform to
track progress towards key goals.
“As one of the busiest trauma centers in the country, we need to
be efficient about how we drive improvement. Our physicians use
evidence-based medicine to treat patients, so it only makes sense
that physician leaders and administrators need to make
evidence-based health care delivery decisions,” said Kito Lord, MD,
MBA, Senior Medical Director and Physician Advisor at Regional One
Health. “Domo takes complex information and helps simplify it,
giving us the evidence we need through real-time data to drive
innovation, make better decisions, and improve patient
outcomes.”
Using Domo, Regional One Health was able to streamline care
practices through data visualizations, reduce patient length of
stay at the center, improve patient access to prescriptions and
decrease harmful events for patients.
In addition to tracking important care metrics, Regional One
Health created pharmacy billing and collections databases with
Domo, which included a catalog of decision support applications and
dashboards to optimize operations for pharmacies within the
hospital. These improvements helped cut expenses by $100,000
annually and double Regional One Health’s revenue capture rate.
“We talk a lot about multiplying impact through data and
Regional One Health embodies absolutely that in their day to day
work,” said Mark Maughan, SVP of customer success at Domo. “The
data experience innovations they have created deliver monumental
gains for the organization and most importantly, help to change
lives.”
To read the full Regional One Health case study, visit here.
About Nucleus Research
Nucleus Research is the recognized global leader in ROI
technology research. Using a case-based approach, we provide
research streams and advisory services that allow vendors and end
users to quantify and maximize the return from their technology
investments. For more information, visit NucleusResearch.com or
follow our latest updates on LinkedIn.
About Domo
Domo puts data to work for everyone so they can multiply their
impact on the business. Our cloud-native data experience platform
goes beyond traditional business intelligence and analytics, making
data visible and actionable with user-friendly dashboards and apps.
Underpinned by AI, data science and a secure data foundation that
connects with existing cloud and legacy systems, Domo helps
companies optimize critical business processes at scale and in
record time to spark the bold curiosity that powers exponential
business results.
For more information, visit www.domo.com. You can also follow
Domo on Twitter, Facebook and LinkedIn.
Domo is a registered trademark of Domo, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230918910746/en/
Cynthia Cowen PR@domo.com
Domo (NASDAQ:DOMO)
過去 株価チャート
から 4 2024 まで 5 2024
Domo (NASDAQ:DOMO)
過去 株価チャート
から 5 2023 まで 5 2024